Clovis: Evaluating The Prospects Of A Possible Acquisition

Stock Information for Corium International Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Corium International Inc.

Corium, Inc. Announces FDA Filing Acceptance of New Drug Application for ADLARITY® (donepezil transdermal system) for the Treatment of Alzheimer's Disease
Corium Appoints Perry Sternberg as Chief Executive Officer
Corium Announces Offer to Purchase for Cash Any and All of the $120,000,000 Aggregate Outstanding Principal Amount of 5.00% Convertible Senior Notes due 2025
Bragar Eagel & Squire, P.C. Reminds Investors that it is Investigating the Boards of Directors of Corium, Hamilton, and Penn Virginia on Behalf of Stockholders and Encourages Investors to Contact the Firm
Lifshitz & Miller LLP Announces Investigation of Corium International, Inc., Dragon Victory International Limited, Honeywell International Inc., Hortonworks, Inc., Idaho Independent Bank, L3 Technologies, Inc., MBT Financial Corp., Nevro Corp., and Ormat
MERGER ALERT - CORI and ESIO: Levi & Korsinsky, LLP Reminds Investors of Investigations Concerning the Sale of these Companies
Bragar Eagel & Squire, P.C. Reminds Investors that it is Investigating the Boards of Directors of Corium, L3, SendGrid, and InfraREIT on Behalf of Stockholders and Encourages Investors to Contact the Firm
MERGER ALERT - CORI, ESL and IMPV: Levi & Korsinsky, LLP Reminds Investors of Investigations Concerning the Sale of these Companies

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.